东方生物(688298.SH)上半年净亏损1.63亿元

Core Viewpoint - Dongfang Biological (688298.SH) reported a decline in revenue and an increase in net loss for the first half of 2025 compared to the previous year [1] Financial Performance - The company achieved an operating revenue of 403 million yuan in the first half of 2025, representing a year-on-year decrease of 3.62% [1] - The net profit attributable to shareholders of the parent company was -163 million yuan, which is an increase in loss of 11.49 million yuan compared to the same period last year [1] - The basic earnings per share were -0.84 yuan [1]